NEW YORK - Nukkleus Inc. (NASDAQ: NUKK), a $53.37 million market cap company whose stock has surged over 1,000% in the past six months according to InvestingPro data, has announced a strategic ...
Nukkleus (NUKK) has partnered with Translink Corporate Finance to identify acquisition opportunities in the air defense ...
EST Nukkleus (NUKK) up 11% afterhours at $28.47 on Translink pactInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to ...
AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, ...
Innocan Pharma Corporation ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global (BI), successfully ...
Nukkleus Inc. (NASDAQ: NUKK) has partnered with Translink Corporate Finance to identify acquisition opportunities in the air defense sector, leveraging Translink's extensive expertise in mergers and ...
NEW YORK - Nukkleus Inc. (NASDAQ: NUKK), a Nasdaq-listed company specializing in the acquisition of high-potential businesses, announced the strategic appointment of Brigadier General (Ret.) Mark ...
Nukkleus Inc. (NASDAQ: NUKK) is proud to announce the appointment of Brigadier General (Ret.) Mark Beesley as Strategic ...
Zeo Energy Corp. (Nasdaq: ZEO) ("Zeo", "Zeo Energy", or the "Company"), a leading Florida-based provider of residential solar and energy efficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback